Full Archive

What a wacky week!

As the diabetes community heads off to Florence for the latest diabetes toy fair it’s not a bad idea to look at the week that was and what to expect from the toy fair. So, let’s get right too it. Yesterday Senseonics reported results, and this is what stuck out – they expect their GLOBAL net revenue for the FIRST HALF of 2024 to reach … wait for it … $10...

Time to take a leap.

In case you haven’t noticed today is February 29th an event that occurs in each year that is a multiple of 4. Which must pretty cool if you happen to be born on this day as you get your choice of celebrating your birthday on two straight during non-leap years. It also gives you the option for some creative Kentucky math as technically you would only age one year for...

Another One Bites The Dust

It never ceases to amaze me the lengths a company will go to just to avoid looking like a fool. Yesterday we learned what we pretty much knew since Abbott acquired Bigfoot that they will not be commercializing the Unity system. See Abbott didn’t buy Bigfoot to add a new product line. No Abbott bought Bigfoot for the same reason JNJ bought Animas, they invested heavily in the company. Others...

The Alternate Universe

Over the past five full trading sessions 24.5% of the shares outstanding have changed hands and the stock is up almost 18% over that time frame. If you narrow the time frame to the last three full sessions the stock is up almost 30% with 18% of the shares outstanding changing hands. This is the situation Tandem finds themselves in and such a dramatic move requires an explanation. As we noted...

Is Roche Coming Back?

Just when you think you have seen it all the wacky world of diabetes proves you wrong. Over the last two trading sessions shares of Tandem are up almost 30% with more than 12% of shares outstanding trading over that time span. (Shares are up again in early trading this morning.) This move comes after earnings which were less than stellular and an outlook that was so so at best. Just...

What they are up against

While most normal people were paying attention to the Insulet earnings announcement another Omnipod wannabe Modular Medical was out raising more money. This wannabe raised $10 million which should allow them to stick around just a little longer. Now I’m not sure just how many Omnipod wannabes there are but before everyone says they stand a chance take a look at what they are up against. Here is a summary of...

Beyond Wacky

Just when you think you have seen it all the wacky world of diabetes gets wackier. Yesterday Tandem reports terrible earnings provides a downbeat outlook for 2024 so naturally today shares go up almost 11%. This afternoon Insulet reports outstanding results so naturally in after-hours trading shares are headed south. Now perhaps this is a sign of good things to come for Insulet as the initial reaction to Tandem’s earnings...